Imperial College London


Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Chair in Metabolic Medicine and Endocrinology



+44 (0)20 3313 8038t.tan




6N6ECommonwealth BuildingHammersmith Campus





Dr Tricia Tan is a Consultant in Diabetes, Endocrinology and Metabolic Medicine at Imperial College London and NHS Trust. She possesses over 10 years’ experience in gut hormone research and physiological studies into the impact of gut hormones on weight and T2DM. She has completed several Phase I trials on the gut hormone analogues, which are being developed for the treatment of obesity. She is the director of the SAS Gut Hormone service, and her clinical research spans a wide gamut from the diagnosis and treatment of neuroendocrine tumours to diagnostic testing in Endocrine disorders.



Lagou V, Jiang L, Ulrich A, et al., 2023, GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification., Nat Genet, Vol:55, Pages:1448-1461

Izzi-Engbeaya C, Patel B, Mills E, et al., 2023, The effects of kisspeptin on food intake in women with overweight or obesity, Diabetes, Obesity and Metabolism: a Journal of Pharmacology and Therapeutics, Vol:25, ISSN:1462-8902, Pages:2393-2397

Wewer Albrechtsen NJ, Holst JJ, Cherrington AD, et al., 2023, 100 years of glucagon and 100 more., Diabetologia, Vol:66, Pages:1378-1394

Avari P, Tang W, Jugnee N, et al., 2023, The Accuracy of Continuous Glucose Sensors in People with Diabetes Undergoing Hemodialysis (ALPHA Study)., Diabetes Technol Ther, Vol:25, Pages:447-456

Behary P, Alessimii H, Miras AD, et al., 2023, Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: a secondary analysis of a randomized single-blind placebo-controlled study, Diabetes, Obesity and Metabolism: a Journal of Pharmacology and Therapeutics, Vol:25, ISSN:1462-8902, Pages:1731-1739

More Publications